Monkeypox declared global health emergency

Global News

The move marks the seventh declared global health emergency since 2009

For the second time in two years, WHO has declared a global health emergency, this time for monkeypox. The declaration is the strongest call to action the agency can make.

Monkeypox has spread in just a few weeks to dozens of countries, and infected tens of thousands.

It is the seventh time such a declaration has been made since 2009, the most recent being for COVID-19. The declaration follows a meeting of a committee of experts on Thursday.

WHO Director General Dr Tedros Adhanom Ghebreyesus shared: “WHO's assessment is that the risk of monkeypox is moderate globally and in all regions, except in the European region, where we assess the risk as high.”

“In short, we have an outbreak that has spread around the world rapidly through new modes of transmission about which we understand too little, and which meets the criteria in the international health regulations,” Dr Tedros continued. “For all of these reasons I have decided that the global monkeypox outbreak represents a global health emergency of international concern.”

The move apparently marks the first time that the director general had sidestepped his advisers to declare an emergency.

Dr Boghuma Titanji, an Infectious Diseases physician at Emory University in Atlanta, US, commented that the move was overdue, and with the delay, “one can argue that the response globally has continued to suffer from a lack of coordination with individual countries working at very different paces to address the problem.”

“There is almost capitulation that we cannot stop the monkeypox virus from establishing itself in a more permanent way,” she added.

“We’ve now unfortunately really missed the boat on being able to put a lid on the outbreak earlier,” Dr James Lawler, co-director of the University of Nebraska’s Global Centre for Health Security, said. “Now it’s going to be a real struggle to be able to contain and control spread.”

Lawler estimated that it may take a year or more to control the outbreak, by which point the virus is likely to have infected hundreds of thousands of people. Additionally, monkeypox may have already now permanently entrenched itself in some countries.

Companies showcase innovative biotech at American Association for Cancer Research

Leading companies in the biotechnology sector have showcased their latest innovations at the American Association for Cancer Research (AACR) meeting that was held in Florida, US, between 14-19 April. The three companies below are a selection of those with positive improvements in solid-tumour treatments.

FDA approves world’s first RSV vaccine

The US Food and Drug Administration (FDA) has announced that it has approved the world’s first respiratory syncytial virus (RSV) vaccine for use in the US in individuals aged 60 or over.

FDA issues update around changes to COVID-19 vaccines’ EUAs

The FDA has announced its amendment of the emergency use authorisations (EUAs) for the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines in an attempt to simplify the vaccination programme.

Johnson & Johnson warns of dangers of Benadryl TikTok challenge

Following the death of a 13-year-old boy who took part in an online ‘challenge’ to take a large amount of the antihistamine, Benadryl (diphenhydramine), manufacturer Johnson & Johnson (J&J) has issued a statement warning of the dangers of overdosing with the drug.

Liberal states begin stockpiling abortion medications following Texas court ruling

Various liberal US states, including California and Massachusetts, have begun stockpiling abortion medications following Texas judge Matthew Kacsmaryk’s attempt to invalidate the long-standing approval of mifepristone, one of the pills used in medication abortions.

Companies showcase innovative biotech at American Association for Cancer Research

FDA approves world’s first RSV vaccine

FDA issues update around changes to COVID-19 vaccines’ EUAs

Johnson & Johnson warns of dangers of Benadryl TikTok challenge

Liberal states begin stockpiling abortion medications following Texas court ruling

Pharmafocus

Categories

Social Footprints